Keefe Bruyette lowered the firm’s price target on Hercules Capital (HTGC) to $18 from $19 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HTGC:
- Hercules Capital Faces Securities Lawsuit Over Alleged Due Diligence and Valuation Misrepresentations
- Hercules Capital price target lowered to $16.50 from $17.50 at Piper Sandler
- Gitlab, Altimmune, Cheniere, Pacific Biosciences, Hercules Shock Wall Street
- HTGC Investor Alert: Hercules Capital Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Valuation Process Deficiencies: Levi & Korsinsky
- Hercules Capital price target lowered to $15 from $19.50 at UBS